Although, these findings suggest that the ATX‐lyso‐PA axis could be an important mediator in the association between high‐risk obesity and a broad range of cardiometabolic diseases, whether interventions targeting weight loss influence plasma ATX levels is unknown. The gene discussed is ENPP2; the disease is obesity due to melanocortin 4 receptor deficiency.